NRx Pharmaceuticals, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 87.0K | $185.28K | 0.00% | Unchanged | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-14upcoming | -0.13 | — | — |
| 2026-05-15 | -0.11 | -0.04 | +59.64% |
| 2026-03-23 | -0.08 | 0.18 | +329.13% |
| 2025-11-14 | -0.02 | -0.51 | -2938.39% |
| 2025-08-18 | -0.23 | -0.98 | -326.09% |
| 2025-05-15 | -0.25 | -0.34 | -36.00% |
| 2025-03-14 | -0.37 | -0.77 | -108.11% |
| 2024-11-14 | -0.66 | -0.15 | +77.27% |
| 2024-08-14 | -0.69 | -0.75 | -7.91% |
| 2024-05-14 | -0.55 | -0.74 | -34.55% |
| 2024-03-29 | -0.80 | -0.50 | +37.50% |
| 2023-11-13 | -1.15 | -0.70 | +39.13% |
| 2023-08-14 | -1.40 | -1.20 | +14.29% |
| 2023-05-15 | -1.30 | -1.60 | -23.08% |
| 2023-03-30 | -1.45 | -1.60 | -10.34% |
| 2022-11-14 | -1.40 | -1.40 | — |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| NRXP | +43.04% | +145.56% | +63.10% | +67.42% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +40.07% | +150.19% | +66.54% | +54.74% |